Search filters

Buparlisib plus fulvestrant in postmenopausal women with hormone-receptor-positive, HER2-negative, advanced breast cancer progressing on or after mTOR inhibition (BELLE-3): a randomised, double-blind, placebo-controlled, phase 3 trial

Image Image of a generic work. The text above it indicates that there is no free image of the work available, and that if you own one, you can click on the placeholder link to upload it.
Description scientific article published on 6 December 2017
Author/s

author: Angelo Di Leo  Thomas Bachelot  Per Eystein Lønning  Ruth M O'Regan 

Publication date December 6, 2017
Language
Country of origin
Wikipedia link
Copyright status
Missing/wrong data? Edit Wikidata item